Table of Contents
ISRN Oncology
Volume 2011 (2011), Article ID 915925, 9 pages
http://dx.doi.org/10.5402/2011/915925
Review Article

Papillary Thyroid Carcinoma: Differential Diagnosis and Prognostic Values of Its Different Variants: Review of the Literature

1Universidad Autónoma Metropolitana, México City, Mexico
2School of Dentistry, Research Department, Universidad Juárez del Estado de Durango (UJED), Durango, Mexico
3Health Care Department, Universidad Autónoma Metropolitana, Xochimilco, Mexico City, Mexico
4Instituto Nacional de Oncología y Radiobiología (INOR), La Habana 10400, Cuba

Received 13 August 2011; Accepted 7 September 2011

Academic Editors: C. Piazza and A. H. Wolfson

Copyright © 2011 Rogelio Gonzalez-Gonzalez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Kukora, “Thyroid cancer,” in Current Surgical Treatment, J. L. Cameron, Ed., pp. 583–589, 2001. View at Google Scholar
  2. H. Erdem, C. Gündogdu Cemal, and S. Üipal, “Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma,” Experimental and Molecular Pathology, vol. 90, no. 3, pp. 312–317, 2011. View at Publisher · View at Google Scholar
  3. M. N. Nikiforova, E. T. Kimura, M. Gandhi et al., “BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5399–5404, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Wada, K. Masudo, H. Nakayama et al., “Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age,” European Journal of Surgical Oncology, vol. 34, no. 2, pp. 202–207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Chow, S. C. K. Law, W. M. Mendenhall et al., “Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 52, no. 3, pp. 784–795, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Wada, Q. Y. Duh, K. Sugino et al., “Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection,” Annals of Surgery, vol. 237, no. 3, pp. 399–407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Machens, H. J. Holzhausen, C. Lautenschläger, P. N. Thanh, and H. Dralle, “Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma: a multivariate analysis of clinical risk factors,” Cancer, vol. 98, no. 4, pp. 712–719, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. N. J. P. Beasley, J. Lee, S. Eski, P. Walfish, I. Witterick, and J. L. Freeman, “Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer,” Archives of Otolaryngology—Head and Neck Surgery, vol. 128, no. 7, pp. 825–828, 2002. View at Google Scholar · View at Scopus
  9. B. J. Lee, S. G. Wang, J. C. Lee, S. M. Son, I. J. Kim, and Y. K. Kim, “Level IIb lymph node metastasis in neck dissection for papillary thyroid carcinoma,” Archives of Otolaryngology—Head and Neck Surgery, vol. 133, no. 10, pp. 1028–1030, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. L. M. Wu, H. Y. Gu, X. H. Qu et al., “The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: a meta-analysis,” European Journal of Radiology. In Press. View at Publisher · View at Google Scholar
  11. J. Hoie, A. E. Stenwig, G. Kullmann, and M. Lindegaard, “Distant metastases in papillary thyroid cancer: a review of 91 patients,” Cancer, vol. 61, no. 1, pp. 1–6, 1988. View at Google Scholar · View at Scopus
  12. J. Albores-Saavedra and K. Carrick, “Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid,” Endocrine Pathology, vol. 15, no. 4, pp. 297–305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. I. D. Hay, E. J. Bergstralh, J. R. Goellner et al., “Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989,” Surgery, vol. 114, no. 6, pp. 1057–1058, 1993. View at Google Scholar · View at Scopus
  14. I. D. Hay, C. S. Grant, E. J. Bergstralh et al., “Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?” Surgery, vol. 124, no. 6, pp. 958–964, 1998. View at Google Scholar · View at Scopus
  15. P. M. Sadow and J. L. Hunt, “Update on clinically important variants of papillary thyroid carcinoma,” Diagnostic Histopathology, vol. 17, no. 3, pp. 106–113, 2011. View at Publisher · View at Google Scholar
  16. Z. W. Baloch and V. A. Livolsi, “Pathology of thyroid and parathyroid diseases,” in Sternberg's Diagnostic Surgical Pathology, S. E. Mills, Ed., pp. 557–619, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 2004. View at Google Scholar
  17. A. K. Y. Lam and C. Y. Lo, “Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution,” Annals of Surgical Oncology, vol. 13, no. 2, pp. 176–181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Mizukami, A. Nonomura, T. Michigishi et al., “Diffuse sclerosing variant of papillary carcinoma of the thyroid: report of three cases,” Acta Pathologica Japonica, vol. 40, no. 9, pp. 676–682, 1990. View at Google Scholar · View at Scopus
  19. C. Regalbuto, P. Malandrino, A. Tumminia, R. Le Moli, R. Vigneri, and V. Pezzino, “A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases,” Thyroid, vol. 21, no. 4, pp. 383–389, 2011. View at Publisher · View at Google Scholar
  20. C. E. Silver, R. P. Owen, J. P. Rodrigo, A. Rinaldo, K. O. Devaney, and A. Ferlito, “Aggressive variants of papillary thyroid carcinoma,” Head and Neck, vol. 33, no. 7, pp. 1052–1059, 2011. View at Publisher · View at Google Scholar
  21. J. Rosai, “Thyroid gland,” in Rosai and Ackerman's Surgical Pathology, J. Rosai and L. Ackerman, Eds., pp. 515–594, Mosby, Edinburgh, Scotland, 9th edition, 2004. View at Google Scholar
  22. S. M. Chow, J. K. C. Chan, S. C. K. Law et al., “Diffuse sclerosing variant of papillary thyroid carcinoma-clinical features and outcome,” European Journal of Surgical Oncology, vol. 29, no. 5, pp. 446–449, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Falvo, L. Giacomelli, V. D'Andrea, A. Marzullo, G. Guerriero, and E. De Antoni, “Prognostic importance of sclerosing variant in papillary thyroid carcinoma,” The American Surgeon, vol. 72, no. 5, pp. 438–444, 2006. View at Google Scholar · View at Scopus
  24. S. Y. Sheu, S. Schwertheim, K. Worm, F. Grabellus, and K. W. Schmid, “Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements,” Modern Pathology, vol. 20, no. 7, pp. 779–787, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Y. Kwak, E. K. Kim, W. H. Soon et al., “Diffuse sclerosing variant of papillary carcinoma of the thyroid gland: specimen radiographic features with histopathological correlation,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 5, pp. 1491–1492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. W. A. Hawk and J. B. Hazard, “The many appearances of papillary carcinoma of the thyroid,” Cleveland Clinic Quarterly, vol. 43, no. 4, pp. 207–215, 1976. View at Google Scholar · View at Scopus
  27. M. J. Merino and C. Monteagudo, “Tall cell carcinoma of the thyroid: an aggressive variant of papillary cancer,” Pathology Case Reviews, vol. 2, pp. 196–199, 1997. View at Google Scholar
  28. S. Jalisi, T. Ainsworth, and M. LaValley, “Prognostic outcomes of tall cell variant papillary throid cancer: a meta-analysis,” Journal of Thyroid Research, vol. 2010, Article ID 325602, 4 pages, 2010. View at Publisher · View at Google Scholar
  29. Y. J. Choi, J. H. Shin, J. H. Kim, S. L. Jung, E. J. Son, and Y. L. Oh, “Tall cell variant of papillary thyroid carcinoma: sonographic and clinical findings,” Journal of Ultrasound in Medicine, vol. 30, no. 6, pp. 853–858, 2011. View at Google Scholar
  30. J. Sutak, J. S. Armstrong, and J. E. Rusby, “Squamous cell carcinoma arising in a tall cell papillary carcinoma of the thyroid,” Journal of Clinical Pathology, vol. 58, no. 6, pp. 662–664, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. B. K. Chen, Y. Ohtsuki, M. Furihata et al., “Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage,” Pathology Research and Practice, vol. 195, no. 6, pp. 427–433, 1999. View at Google Scholar · View at Scopus
  32. S. Scarpino, A. Stoppacciaro, C. Colarossi et al., “Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid,” Journal of Pathology, vol. 189, no. 4, pp. 570–575, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Zanetti, A. Stoppacciaro, A. Marzullo et al., “Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid,” Journal of Pathology, vol. 186, no. 3, pp. 287–291, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Basolo, R. Giannini, C. Monaco et al., “Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma,” American Journal of Pathology, vol. 160, no. 1, pp. 247–254, 2002. View at Google Scholar · View at Scopus
  35. E. Campo, M. J. Merino, L. Liotta, R. Neumann, and W. Stetler-Stevenson, “Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue,” Human Pathology, vol. 23, no. 12, pp. 1395–1401, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Rivera, R. A. Ghossein, H. Schoder, D. Gomez, S. M. Larson, and R. M. Tuttle, “Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma,” Cancer, vol. 113, no. 1, pp. 48–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Nikiforov, D. R. Gnepp, and J. A. Fagin, “Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 1, pp. 9–14, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Ugolini, P. Agnese, and B. Fulvio, “The role of BRAFV600E mutation in the management of thyroid papillary carcinoma,” Pathology Case Reviews, vol. 14, no. 6, pp. 231–235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. E. Nikiforov, L. A. Erickson, M. N. Nikiforova, C. M. Caudill, and R. V. Lloyd, “Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior,” American Journal of Surgical Pathology, vol. 25, no. 12, pp. 1478–1484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Hedinger, E. D. Williams, and L. H. Sobin, “The WHO histological classification of thyroid tumors: a commentary on the second edition,” Cancer, vol. 63, no. 5, pp. 908–911, 1989. View at Google Scholar · View at Scopus
  41. G. H. Sakorafas, J. Giotakis, and V. Stafyla, “Papillary thyroid microcarcinoma: a surgical perspective,” Cancer Treatment Reviews, vol. 31, no. 6, pp. 423–438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. R. Pelizzo, I. M. Boschin, A. Toniato et al., “Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients,” European Journal of Surgical Oncology, vol. 32, no. 10, pp. 1144–1148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Appetecchia, G. Scarcello, E. Pucci, and A. Procaccini, “Outcome after treatment of papillary thyroid microcarcinoma,” Journal of Experimental and Clinical Cancer Research, vol. 21, no. 2, pp. 159–164, 2002. View at Google Scholar · View at Scopus
  44. R. Bologna-Molina, R. González-González, A. Mosqueda-Taylor, N. Molina-Frechero, P. Damián-Matsumura, and H. Dominguez-Malagón, “Expression of syndecan-1 in papillary carcinoma of the thyroid with extracapsular invasion,” Archives of Medical Research, vol. 41, no. 1, pp. 33–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Dunki-Jacobs, K. Grannan, S. McDonough, and A. M. Engel, “Clinically unsuspected papillary microcarcinomas of the thyroid: a common finding with favorable biology?” The American Journal of Surgery. In Press. View at Publisher · View at Google Scholar
  46. Y. Ito, C. Tomoda, T. Uruno et al., “Papillary microcarcinoma of the thyroid: how should it be treated?” World Journal of Surgery, vol. 28, no. 11, pp. 1115–1121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. H. L. Evans, “Columnar-cell carcinoma of the thyroid: a report of two cases of an aggressive variant of thyroid carcinoma,” American Journal of Clinical Pathology, vol. 85, no. 1, pp. 77–80, 1986. View at Google Scholar · View at Scopus
  48. D. Berends and P. J. Mouthaan, “Columnar-cell carcinoma of the thyroid,” Histopathology, vol. 20, no. 4, pp. 360–632, 1992. View at Google Scholar · View at Scopus
  49. M. Sobrinho-Simoes, J. M. Nesland, and J. V. Johannessen, “Columnar-cell carcinoma: another variant of poorly differentiated carcinoma of the thyroid,” American Journal of Clinical Pathology, vol. 89, no. 2, pp. 264–267, 1988. View at Google Scholar · View at Scopus
  50. M. Sywak, J. L. Pasieka, and T. Ogilvie, “A review of thyroid cancer with intermediate differentiation,” Journal of Surgical Oncology, vol. 86, no. 1, pp. 44–54, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. J. H. Chen, W. C. Faquin, R. V. Lloyd, and V. Nosé, “Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma,” Modern Pathology, vol. 24, no. 5, pp. 739–749, 2011. View at Publisher · View at Google Scholar
  52. R. A. DeLellis and E. D. Williams, “Thyroid and parathyroid tumours: papillary carcinoma,” in World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs, R. A. DeLellis, R. V. Lloyd, P. U. Heitz, and C. Eng, Eds., pp. 57–66, IARC Press, Lyon, France, 2004. View at Google Scholar
  53. D. Variakojis, M. L. Getz, E. Paloyan, and F. H. Straus, “Papillary clear cell carcinoma of the thyroid gland,” Human Pathology, vol. 6, no. 3, pp. 384–390, 1975. View at Google Scholar · View at Scopus
  54. H. R. Harach, G. T. Williams, and E. D. Williams, “Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm,” Histopathology, vol. 25, no. 6, pp. 549–561, 1994. View at Google Scholar · View at Scopus
  55. S. B. Ng, K. Sittampalam, Y. H. Goh, and K. W. Eu, “Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma: a case report with clinical and molecular genetic correlation,” Pathology, vol. 35, no. 1, pp. 42–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Chikkamuniyappa and J. Jagirdar, “Cribriform-morular variant of papillary carcinoma: association with familial adenomatous polyposis—report of three cases and review of literature,” International Journal Medicine Science, vol. 1, no. 1, pp. 43–49, 2004. View at Google Scholar
  57. M. Miyaki, T. Iijima, R. Ishii et al., “Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis,” American Journal of Pathology, vol. 157, no. 6, pp. 1825–1827, 2000. View at Google Scholar · View at Scopus
  58. J. Cameselle-Teijeiro and J. K. Chan, “Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma?” Modern Pathology, vol. 13, no. 3, pp. 363–365, 1999. View at Google Scholar · View at Scopus
  59. M. Hirokawa, S. Kuma, A. Miyauchi et al., “Morules in cribriform-morular variant of papillary thyroid carcinoma: immunohistochemical characteristics and distinction from squamous metaplasia,” Acta Pathologica Microbiologica et Immunologica, vol. 112, no. 4-5, pp. 275–282, 2004. View at Publisher · View at Google Scholar
  60. J. Cameselle-Teijeiro, L. P. Menasce, B. K. Yap et al., “Cribriform-morular variant of papillary thyroid carcinoma molecular characterization of a case with neuroendocrine differentiation and aggressive behavior,” American Journal of Clinical Pathology, vol. 131, no. 1, pp. 134–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. V. K. Shubadha and I. N. Bagwan, “Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma,” Oral Oncology Extra, vol. 42, no. 4, pp. 167–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Tallini, A. Hsueh, S. Liu, G. Garcia-Rostan, M. R. Speicher, and D. C. Ward, “Frequent chromosomal DNA unbalance in thyroid oncocytic (Hurthle cell) neoplasms detected by comparative genomic hybridization,” Laboratory Investigation, vol. 79, no. 5, pp. 547–555, 1999. View at Google Scholar · View at Scopus
  63. J. Tscholl-Ducommun and C. E. Hedinger, “Papillary thyroid carcinomas: morphology and prognosis,” Virchows Archiv A, vol. 396, no. 1, pp. 19–39, 1982. View at Google Scholar · View at Scopus
  64. M. Berho and S. Suster, “The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases,” Human Pathology, vol. 28, no. 1, pp. 47–53, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. R. L. Apel, S. L. Asa, and V. A. LiVolsi, “Papillary Hurthle cell carcinoma with lymphocytic stroma: “Warthin-like tumor” of the thyroid,” American Journal of Surgical Pathology, vol. 19, no. 7, pp. 810–814, 1995. View at Google Scholar · View at Scopus
  66. W. A. Hawk and J. B. Hazard, “The many appearances of papillary carcinoma of the thyroid: comparison with the common form of papillary carcinoma by DNA and morphometric analysis,” Cleveland Clinic Quarterly, vol. 43, no. 4, pp. 207–215, 1976. View at Google Scholar
  67. M. A. Sobrinho-Simoes, J. M. Nesland, and R. Holm, “Hurthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study,” Ultrastructural Pathology, vol. 8, no. 2-3, pp. 131–142, 1985. View at Google Scholar · View at Scopus
  68. A. K. Y. Lam, C. Y. Lo, and K. S. L. Lam, “Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants,” Endocrine Pathology, vol. 16, no. 4, pp. 323–330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Salajegheh, E. B. Petcu, R. A. Smith, and A. K. Y. Lam, “Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists,” Postgraduate Medical Journal, vol. 84, no. 988, pp. 78–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. B. H. H. Lang, C. Y. Lo, W. F. Chan, A. K. Y. Lam, and K. Y. Wan, “Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome,” World Journal of Surgery, vol. 30, no. 5, pp. 752–758, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. S. R. Kini, J. M. Miller, J. I. Hamburger, and M. J. Smith, “Cytopathology of papillary carcinoma of the thyroid by fine needle aspiration,” Acta Cytologica, vol. 24, no. 6, pp. 511–521, 1980. View at Google Scholar · View at Scopus
  72. P. U. Shen, W. I. Kuhel, G. C. Yang, and S. A. Hoda, “Intraoperative touch-imprint cytological diagnosis of follicular variant of papillary thyroid carcinoma,” Diagnostic Cytopathology, vol. 17, no. 1, pp. 80–83, 1997. View at Google Scholar · View at Scopus
  73. S. B. Kesmodel, K. P. Terhune, R. J. Canter et al., “The diagnostic dilemma of follicular variant of papillary thyroid carcinoma,” Surgery, vol. 134, no. 6, pp. 1005–1012, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. L. J. DeGroot, E. L. Kaplan, M. McCormick, and F. H. Straus, “Natural history, treatment, and course of papillary thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 71, no. 2, pp. 414–424, 1990. View at Google Scholar · View at Scopus
  75. R. V. Lloyd, L. A. Erickson, M. B. Casey et al., “Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma,” The American Journal of Surgical Pathology, vol. 28, no. 10, pp. 1336–1340, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. J. R. Burgess, “Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997),” Thyroid, vol. 12, no. 2, pp. 141–149, 2002. View at Google Scholar · View at Scopus
  77. J. A. Fagin and N. Mitsiades, “Molecular pathology of thyroid cancer: diagnostic and clinical implications,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 22, no. 6, pp. 955–969, 2008. View at Publisher · View at Google Scholar · View at Scopus